| 0 |
FLT3 GENE MUTATION |
13 |
0.8667 |
| 1 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
62 |
0.3605 |
| 2 |
ALLOGENIC STEM CELL TRANSPLANTATION |
52 |
0.3291 |
| 3 |
CORYNEBACTERIUM BACTERAEMIA |
26 |
0.3059 |
| 4 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
617 |
0.2871 |
| 5 |
PROTOTHECOSIS |
25 |
0.2660 |
| 6 |
ACUTE MYELOID LEUKAEMIA (IN REMISSION) |
9 |
0.2647 |
| 7 |
EMPHYSEMATOUS CHOLECYSTITIS |
13 |
0.2600 |
| 8 |
MYELODYSPLASTIC SYNDROME TRANSFORMATION |
129 |
0.2476 |
| 9 |
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA |
20 |
0.2469 |
| 10 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
143 |
0.2180 |
| 11 |
CORD BLOOD TRANSPLANT THERAPY |
18 |
0.2118 |
| 12 |
BLAST CELL COUNT INCREASED |
190 |
0.1813 |
| 13 |
BACILLUS BACTERAEMIA |
19 |
0.1743 |
| 14 |
CHIMERISM |
14 |
0.1573 |
| 15 |
BLAST CELL COUNT DECREASED |
11 |
0.1507 |
| 16 |
ACUTE MYELOID LEUKAEMIA |
2227 |
0.1427 |
| 17 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
90 |
0.1364 |
| 18 |
LEUKOSTASIS SYNDROME |
18 |
0.1353 |
| 19 |
ERYTHROLEUKAEMIA |
10 |
0.1316 |
| 20 |
CYTARABINE SYNDROME |
10 |
0.1316 |
| 21 |
MYELOBLAST COUNT INCREASED |
10 |
0.1299 |
| 22 |
DIFFERENTIATION SYNDROME |
93 |
0.1267 |
| 23 |
PARAINFLUENZA VIRUS INFECTION |
13 |
0.1262 |
| 24 |
MINIMAL RESIDUAL DISEASE |
59 |
0.1222 |
| 25 |
BLOOD PRODUCT TRANSFUSION DEPENDENT |
49 |
0.1164 |
| 26 |
MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS |
12 |
0.0984 |
| 27 |
CHLOROMA |
41 |
0.0972 |
| 28 |
CLONAL EVOLUTION |
10 |
0.0962 |
| 29 |
CONGENITAL APLASIA |
29 |
0.0932 |
| 30 |
REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS |
25 |
0.0799 |
| 31 |
GEOTRICHUM INFECTION |
16 |
0.0758 |
| 32 |
RED BLOOD CELL TRANSFUSION |
30 |
0.0732 |
| 33 |
LEUKAEMIA CUTIS |
11 |
0.0714 |
| 34 |
BLAST CELLS PRESENT |
33 |
0.0686 |
| 35 |
PNEUMONIA ADENOVIRAL |
13 |
0.0657 |
| 36 |
AEROMONAS INFECTION |
12 |
0.0635 |
| 37 |
PNEUMONIA FUNGAL |
236 |
0.0598 |
| 38 |
ADENOVIRAL HEPATITIS |
14 |
0.0596 |
| 39 |
BACILLUS INFECTION |
36 |
0.0570 |
| 40 |
GRAFT VERSUS HOST DISEASE IN LIVER |
40 |
0.0559 |
| 41 |
ANORECTAL INFECTION |
14 |
0.0556 |
| 42 |
PLATELET TRANSFUSION |
71 |
0.0551 |
| 43 |
CHRONIC GRAFT VERSUS HOST DISEASE IN EYE |
11 |
0.0542 |
| 44 |
MYELODYSPLASTIC SYNDROME |
780 |
0.0539 |
| 45 |
MYELOSUPPRESSION |
1808 |
0.0501 |
| 46 |
CYTOPENIA |
587 |
0.0479 |
| 47 |
TISSUE INFILTRATION |
14 |
0.0475 |
| 48 |
ANAL INFECTION |
12 |
0.0467 |
| 49 |
MYELOID LEUKAEMIA |
23 |
0.0459 |
| 50 |
FEBRILE NEUTROPENIA |
3035 |
0.0457 |
| 51 |
TUMOUR LYSIS SYNDROME |
400 |
0.0454 |
| 52 |
GRAFT VERSUS HOST DISEASE IN LUNG |
21 |
0.0439 |
| 53 |
PRIMARY MYELOFIBROSIS |
14 |
0.0435 |
| 54 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
11 |
0.0431 |
| 55 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
97 |
0.0417 |
| 56 |
GRANULOCYTE COUNT DECREASED |
77 |
0.0415 |
| 57 |
PSEUDOMONAL BACTERAEMIA |
35 |
0.0410 |
| 58 |
PERIORBITAL CELLULITIS |
22 |
0.0410 |
| 59 |
RHINOCEREBRAL MUCORMYCOSIS |
14 |
0.0403 |
| 60 |
ACUTE MYELOMONOCYTIC LEUKAEMIA |
10 |
0.0397 |
| 61 |
STENOTROPHOMONAS INFECTION |
53 |
0.0391 |
| 62 |
FUSARIUM INFECTION |
26 |
0.0371 |
| 63 |
TUMOUR ASSOCIATED FEVER |
15 |
0.0367 |
| 64 |
GRAFT VERSUS HOST DISEASE IN SKIN |
80 |
0.0363 |
| 65 |
ANGIODYSPLASIA |
13 |
0.0357 |
| 66 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
14 |
0.0356 |
| 67 |
IRON OVERLOAD |
37 |
0.0343 |
| 68 |
LEUKAEMIA RECURRENT |
57 |
0.0337 |
| 69 |
SINUSITIS FUNGAL |
27 |
0.0337 |
| 70 |
SOFT TISSUE INFECTION |
61 |
0.0333 |
| 71 |
TOXIC NEUROPATHY |
13 |
0.0330 |
| 72 |
ACUTE LEUKAEMIA |
53 |
0.0328 |
| 73 |
BRONCHOPULMONARY ASPERGILLOSIS |
254 |
0.0327 |
| 74 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
23 |
0.0320 |
| 75 |
TRANSFUSION REACTION |
28 |
0.0319 |
| 76 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
68 |
0.0319 |
| 77 |
MONOCYTOSIS |
19 |
0.0306 |
| 78 |
FEBRILE INFECTION |
34 |
0.0289 |
| 79 |
PULMONARY SEPSIS |
42 |
0.0289 |
| 80 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
11 |
0.0283 |
| 81 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
13 |
0.0279 |
| 82 |
NEUTROPHILIC DERMATOSIS |
11 |
0.0278 |
| 83 |
KLEBSIELLA SEPSIS |
31 |
0.0275 |
| 84 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
10 |
0.0275 |
| 85 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
76 |
0.0275 |
| 86 |
KLEBSIELLA BACTERAEMIA |
26 |
0.0274 |
| 87 |
NEUTROPENIC INFECTION |
26 |
0.0272 |
| 88 |
SYSTEMIC CANDIDA |
66 |
0.0263 |
| 89 |
ESCHERICHIA BACTERAEMIA |
61 |
0.0259 |
| 90 |
TRANSPLANT |
61 |
0.0257 |
| 91 |
MYELOPROLIFERATIVE NEOPLASM |
17 |
0.0256 |
| 92 |
BIOPSY BONE MARROW |
12 |
0.0256 |
| 93 |
NEUTROPENIC COLITIS |
53 |
0.0256 |
| 94 |
PACKED RED BLOOD CELL TRANSFUSION |
33 |
0.0249 |
| 95 |
ESCHERICHIA SEPSIS |
72 |
0.0248 |
| 96 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
35 |
0.0248 |
| 97 |
PULMONARY MUCORMYCOSIS |
13 |
0.0246 |
| 98 |
FEBRILE BONE MARROW APLASIA |
102 |
0.0240 |
| 99 |
PSEUDOMONAL SEPSIS |
42 |
0.0240 |
| 100 |
TRANSPLANTATION COMPLICATION |
10 |
0.0238 |
| 101 |
MYELOFIBROSIS |
72 |
0.0238 |
| 102 |
NEUTROPENIC SEPSIS |
165 |
0.0231 |
| 103 |
HYPERLEUKOCYTOSIS |
20 |
0.0226 |
| 104 |
HAEMATOTOXICITY |
211 |
0.0222 |
| 105 |
STREPTOCOCCAL BACTERAEMIA |
24 |
0.0221 |
| 106 |
SPLENIC INFARCTION |
38 |
0.0218 |
| 107 |
ENTEROCOCCUS TEST POSITIVE |
14 |
0.0216 |
| 108 |
PALLIATIVE CARE |
33 |
0.0215 |
| 109 |
APLASIA |
42 |
0.0214 |
| 110 |
SYSTEMIC MYCOSIS |
25 |
0.0214 |
| 111 |
NEUTROPHIL COUNT DECREASED |
851 |
0.0209 |
| 112 |
BACTERAEMIA |
246 |
0.0207 |
| 113 |
GRAFT VERSUS HOST DISEASE |
148 |
0.0206 |
| 114 |
ACUTE GRAFT VERSUS HOST DISEASE |
94 |
0.0205 |
| 115 |
BACTERIAL SEPSIS |
66 |
0.0202 |
| 116 |
ENTEROCOCCAL BACTERAEMIA |
21 |
0.0198 |
| 117 |
CYTOGENETIC ABNORMALITY |
22 |
0.0195 |
| 118 |
PULMONARY MYCOSIS |
15 |
0.0193 |
| 119 |
STEM CELL TRANSPLANT |
48 |
0.0192 |
| 120 |
BONE MARROW DISORDER |
58 |
0.0192 |
| 121 |
ENDOCARDITIS BACTERIAL |
15 |
0.0191 |
| 122 |
PANCYTOPENIA |
1066 |
0.0191 |
| 123 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
17 |
0.0190 |
| 124 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
25 |
0.0190 |
| 125 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
16 |
0.0190 |
| 126 |
BONE MARROW TRANSPLANT |
36 |
0.0190 |
| 127 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
17 |
0.0184 |
| 128 |
ORGANISING PNEUMONIA |
91 |
0.0183 |
| 129 |
LEUKAEMIA |
171 |
0.0181 |
| 130 |
MUCORMYCOSIS |
47 |
0.0181 |
| 131 |
SEPTIC EMBOLUS |
15 |
0.0180 |
| 132 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
16 |
0.0173 |
| 133 |
CHRONIC GRAFT VERSUS HOST DISEASE |
62 |
0.0172 |
| 134 |
ENTERITIS INFECTIOUS |
29 |
0.0170 |
| 135 |
STAPHYLOCOCCAL BACTERAEMIA |
74 |
0.0170 |
| 136 |
SCEDOSPORIUM INFECTION |
12 |
0.0170 |
| 137 |
KLEBSIELLA TEST POSITIVE |
11 |
0.0169 |
| 138 |
FUNGAL SEPSIS |
14 |
0.0168 |
| 139 |
INVESTIGATION ABNORMAL |
24 |
0.0167 |
| 140 |
MYOPERICARDITIS |
13 |
0.0167 |
| 141 |
DYSPLASIA |
20 |
0.0167 |
| 142 |
HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL |
10 |
0.0163 |
| 143 |
PNEUMONIA KLEBSIELLA |
30 |
0.0163 |
| 144 |
BLOOD BILIRUBIN DECREASED |
10 |
0.0162 |
| 145 |
SOFT TISSUE NECROSIS |
11 |
0.0160 |
| 146 |
ASPERGILLUS INFECTION |
105 |
0.0160 |
| 147 |
ENTEROCOCCAL INFECTION |
77 |
0.0159 |
| 148 |
FUNGAEMIA |
25 |
0.0159 |
| 149 |
NECROTISING FASCIITIS |
55 |
0.0156 |
| 150 |
VIRAL HAEMORRHAGIC CYSTITIS |
11 |
0.0154 |
| 151 |
STAPHYLOCOCCAL SEPSIS |
76 |
0.0154 |
| 152 |
PYODERMA GANGRENOSUM |
55 |
0.0153 |
| 153 |
ALVEOLAR PROTEINOSIS |
9 |
0.0152 |
| 154 |
ENTEROCOLITIS INFECTIOUS |
14 |
0.0152 |
| 155 |
PARAINFLUENZAE VIRUS INFECTION |
23 |
0.0151 |
| 156 |
BRAIN ABSCESS |
38 |
0.0150 |
| 157 |
NEUTROPENIA |
2019 |
0.0148 |
| 158 |
MARROW HYPERPLASIA |
10 |
0.0147 |
| 159 |
THROMBOCYTOPENIA |
1634 |
0.0146 |
| 160 |
NEUTROPHIL COUNT ABNORMAL |
41 |
0.0145 |
| 161 |
HAEMOPHILUS INFECTION |
14 |
0.0143 |
| 162 |
SEPTIC SHOCK |
614 |
0.0141 |
| 163 |
PLATELET DISORDER |
35 |
0.0139 |
| 164 |
BONE MARROW FAILURE |
279 |
0.0137 |
| 165 |
ENTEROCOCCAL SEPSIS |
11 |
0.0136 |
| 166 |
LUNG CONSOLIDATION |
38 |
0.0136 |
| 167 |
LOCAL REACTION |
10 |
0.0135 |
| 168 |
GINGIVAL ULCERATION |
10 |
0.0133 |
| 169 |
FULL BLOOD COUNT DECREASED |
265 |
0.0131 |
| 170 |
COLONIC ABSCESS |
11 |
0.0129 |
| 171 |
DILATED CARDIOMYOPATHY |
13 |
0.0129 |
| 172 |
URINARY TRACT INFECTION ENTEROCOCCAL |
12 |
0.0128 |
| 173 |
RENAL TUBULAR DISORDER |
36 |
0.0128 |
| 174 |
HAEMOGLOBIN ABNORMAL |
82 |
0.0127 |
| 175 |
HAEMATOLOGICAL INFECTION |
31 |
0.0127 |
| 176 |
KLEBSIELLA INFECTION |
64 |
0.0126 |
| 177 |
ESCHERICHIA TEST POSITIVE |
15 |
0.0125 |
| 178 |
LUNG OPACITY |
33 |
0.0125 |
| 179 |
OESOPHAGEAL CANDIDIASIS |
49 |
0.0123 |
| 180 |
PLATELET COUNT DECREASED |
1297 |
0.0122 |
| 181 |
DISSEMINATED INTRAVASCULAR COAGULATION |
171 |
0.0121 |
| 182 |
TRANSFUSION |
127 |
0.0121 |
| 183 |
VENOOCCLUSIVE DISEASE |
30 |
0.0120 |
| 184 |
JC VIRUS INFECTION |
19 |
0.0119 |
| 185 |
PSEUDOMEMBRANOUS COLITIS |
26 |
0.0116 |
| 186 |
GENE MUTATION |
23 |
0.0116 |
| 187 |
NO THERAPEUTIC RESPONSE |
141 |
0.0116 |
| 188 |
VASCULAR PURPURA |
16 |
0.0115 |
| 189 |
SEPSIS |
1273 |
0.0114 |
| 190 |
VENOOCCLUSIVE LIVER DISEASE |
55 |
0.0111 |
| 191 |
LIVER ABSCESS |
36 |
0.0111 |
| 192 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
83 |
0.0110 |
| 193 |
HAEMORRHAGIC DISORDER |
12 |
0.0110 |
| 194 |
CYSTITIS HAEMORRHAGIC |
44 |
0.0109 |
| 195 |
AGRANULOCYTOSIS |
198 |
0.0106 |
| 196 |
THROMBOCYTOSIS |
39 |
0.0106 |
| 197 |
SERUM FERRITIN INCREASED |
56 |
0.0106 |
| 198 |
PLATELET COUNT ABNORMAL |
63 |
0.0104 |
| 199 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
13 |
0.0103 |
| 200 |
ANAL ABSCESS |
55 |
0.0102 |
| 201 |
WHITE BLOOD CELL COUNT ABNORMAL |
65 |
0.0102 |
| 202 |
WHITE BLOOD CELL DISORDER |
27 |
0.0101 |
| 203 |
MUCOSAL DISORDER |
10 |
0.0101 |
| 204 |
CATHETER SITE INFECTION |
38 |
0.0100 |
| 205 |
BLOOD DISORDER |
80 |
0.0100 |
| 206 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
44 |
0.0100 |
| 207 |
SUBDURAL HAEMATOMA |
140 |
0.0098 |
| 208 |
CLOSTRIDIUM DIFFICILE COLITIS |
101 |
0.0095 |
| 209 |
WHITE BLOOD CELL COUNT DECREASED |
1032 |
0.0095 |
| 210 |
GRANULOCYTOPENIA |
54 |
0.0095 |
| 211 |
ATYPICAL PNEUMONIA |
28 |
0.0094 |
| 212 |
LEUKOCYTOSIS |
167 |
0.0092 |
| 213 |
OBLITERATIVE BRONCHIOLITIS |
12 |
0.0091 |
| 214 |
PSEUDOMONAS INFECTION |
78 |
0.0091 |
| 215 |
MONOCYTE COUNT DECREASED |
11 |
0.0090 |
| 216 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
252 |
0.0089 |
| 217 |
URINARY TRACT OBSTRUCTION |
21 |
0.0088 |
| 218 |
ENTEROCOLITIS |
51 |
0.0088 |
| 219 |
PNEUMONIA BACTERIAL |
81 |
0.0088 |
| 220 |
SIALOADENITIS |
12 |
0.0088 |
| 221 |
HYPERBILIRUBINAEMIA |
91 |
0.0088 |
| 222 |
GASTROINTESTINAL TOXICITY |
42 |
0.0087 |
| 223 |
RENAL TUBULAR ACIDOSIS |
19 |
0.0087 |
| 224 |
STAPHYLOCOCCUS TEST POSITIVE |
18 |
0.0085 |
| 225 |
CAPILLARY LEAK SYNDROME |
17 |
0.0082 |
| 226 |
CARDIAC TAMPONADE |
39 |
0.0082 |
| 227 |
PULMONARY ALVEOLAR HAEMORRHAGE |
46 |
0.0082 |
| 228 |
PNEUMONITIS |
222 |
0.0081 |
| 229 |
OTOTOXICITY |
15 |
0.0081 |
| 230 |
ENTEROCOLITIS HAEMORRHAGIC |
12 |
0.0081 |
| 231 |
GASTRITIS HAEMORRHAGIC |
12 |
0.0080 |
| 232 |
BLOOD IRON INCREASED |
15 |
0.0080 |
| 233 |
LUNG INFILTRATION |
70 |
0.0079 |
| 234 |
GINGIVAL HYPERTROPHY |
12 |
0.0079 |
| 235 |
INFECTION |
1138 |
0.0079 |
| 236 |
SPLENOMEGALY |
92 |
0.0078 |
| 237 |
PERICARDITIS |
130 |
0.0077 |
| 238 |
HYPOALBUMINAEMIA |
60 |
0.0077 |
| 239 |
MYOSITIS |
69 |
0.0077 |
| 240 |
SUBILEUS |
16 |
0.0077 |
| 241 |
BLOOD CULTURE POSITIVE |
23 |
0.0077 |
| 242 |
ASPERGILLOSIS |
10 |
0.0077 |
| 243 |
ANAEMIA |
1443 |
0.0076 |
| 244 |
INTESTINAL ULCER |
12 |
0.0075 |
| 245 |
HYPERPHOSPHATAEMIA |
16 |
0.0074 |
| 246 |
PHLEBITIS |
38 |
0.0074 |
| 247 |
ERYTHEMA NODOSUM |
26 |
0.0074 |
| 248 |
HEPATOSPLENOMEGALY |
19 |
0.0074 |
| 249 |
CYTOMEGALOVIRUS COLITIS |
17 |
0.0074 |
| 250 |
BLOOD PHOSPHORUS INCREASED |
20 |
0.0073 |
| 251 |
ARTHRITIS BACTERIAL |
30 |
0.0073 |
| 252 |
SPLENIC RUPTURE |
12 |
0.0073 |
| 253 |
COVID-19 PNEUMONIA |
85 |
0.0072 |
| 254 |
ESCHERICHIA INFECTION |
59 |
0.0072 |
| 255 |
ACUTE PULMONARY OEDEMA |
40 |
0.0071 |
| 256 |
ENDOCARDITIS |
35 |
0.0068 |
| 257 |
LUNG INFECTION |
106 |
0.0068 |
| 258 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
108 |
0.0068 |
| 259 |
RED BLOOD CELL COUNT ABNORMAL |
10 |
0.0068 |
| 260 |
CACHEXIA |
35 |
0.0068 |
| 261 |
PROCTITIS |
19 |
0.0068 |
| 262 |
PULMONARY HAEMORRHAGE |
53 |
0.0068 |
| 263 |
RED BLOOD CELL COUNT DECREASED |
192 |
0.0067 |
| 264 |
MIXED LIVER INJURY |
20 |
0.0066 |
| 265 |
BICYTOPENIA |
13 |
0.0066 |
| 266 |
LYMPHADENITIS |
16 |
0.0066 |
| 267 |
INFECTIOUS PLEURAL EFFUSION |
10 |
0.0066 |
| 268 |
CLOSTRIDIAL INFECTION |
22 |
0.0065 |
| 269 |
LOBAR PNEUMONIA |
12 |
0.0065 |
| 270 |
DEVICE RELATED SEPSIS |
13 |
0.0065 |
| 271 |
CEREBRAL HAEMORRHAGE |
231 |
0.0064 |
| 272 |
INJECTION SITE NECROSIS |
13 |
0.0064 |
| 273 |
SECOND PRIMARY MALIGNANCY |
53 |
0.0064 |
| 274 |
URINARY TRACT INFECTION BACTERIAL |
16 |
0.0063 |
| 275 |
PNEUMONIA |
2029 |
0.0063 |
| 276 |
ADENOVIRUS INFECTION |
18 |
0.0062 |
| 277 |
PANNICULITIS |
15 |
0.0062 |
| 278 |
PNEUMONIA CYTOMEGALOVIRAL |
12 |
0.0062 |
| 279 |
CARDIAC FAILURE ACUTE |
41 |
0.0061 |
| 280 |
CARDIOPULMONARY FAILURE |
24 |
0.0061 |
| 281 |
CRYPTOCOCCOSIS |
10 |
0.0061 |
| 282 |
HAEMOGLOBIN DECREASED |
627 |
0.0061 |
| 283 |
PERICARDIAL EFFUSION |
141 |
0.0061 |
| 284 |
CHRONIC MYELOID LEUKAEMIA |
28 |
0.0061 |
| 285 |
DERMATITIS EXFOLIATIVE GENERALISED |
21 |
0.0060 |
| 286 |
LEUKOPENIA |
302 |
0.0060 |
| 287 |
HAEMORRHAGE INTRACRANIAL |
90 |
0.0060 |
| 288 |
TROPONIN I INCREASED |
10 |
0.0060 |
| 289 |
ECCHYMOSIS |
41 |
0.0060 |
| 290 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
60 |
0.0060 |
| 291 |
VASCULAR DEVICE INFECTION |
27 |
0.0059 |
| 292 |
APLASTIC ANAEMIA |
31 |
0.0059 |
| 293 |
HAEMORRHAGIC DIATHESIS |
21 |
0.0059 |
| 294 |
CLOSTRIDIUM TEST POSITIVE |
13 |
0.0059 |
| 295 |
DISSEMINATED TUBERCULOSIS |
15 |
0.0058 |
| 296 |
DISEASE PROGRESSION |
691 |
0.0058 |
| 297 |
HYPERURICAEMIA |
24 |
0.0058 |
| 298 |
IMMUNODEFICIENCY |
87 |
0.0058 |
| 299 |
DIVERTICULAR PERFORATION |
12 |
0.0058 |
| 300 |
RESPIRATORY FAILURE |
424 |
0.0058 |
| 301 |
HOSPICE CARE |
57 |
0.0058 |
| 302 |
LUNG ABSCESS |
12 |
0.0057 |
| 303 |
ENDOTRACHEAL INTUBATION |
16 |
0.0057 |
| 304 |
CARDIAC DYSFUNCTION |
21 |
0.0056 |
| 305 |
ATRIAL FLUTTER |
45 |
0.0056 |
| 306 |
HAEMORRHAGE SUBCUTANEOUS |
20 |
0.0056 |
| 307 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
19 |
0.0055 |
| 308 |
SUBARACHNOID HAEMORRHAGE |
56 |
0.0055 |
| 309 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
21 |
0.0055 |
| 310 |
ABDOMINAL INFECTION |
14 |
0.0055 |
| 311 |
ANAL FISSURE |
29 |
0.0054 |
| 312 |
CHOLESTATIC LIVER INJURY |
12 |
0.0054 |
| 313 |
BACTERIAL TEST POSITIVE |
12 |
0.0054 |
| 314 |
NON-CARDIAC CHEST PAIN |
17 |
0.0054 |
| 315 |
BACTERIAL INFECTION |
99 |
0.0053 |
| 316 |
TRANSPLANT FAILURE |
13 |
0.0053 |
| 317 |
CHOLECYSTITIS ACUTE |
30 |
0.0053 |
| 318 |
ATELECTASIS |
51 |
0.0053 |
| 319 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
14 |
0.0053 |
| 320 |
FULL BLOOD COUNT ABNORMAL |
55 |
0.0052 |
| 321 |
FIBROSIS |
16 |
0.0052 |
| 322 |
ERYSIPELAS |
26 |
0.0052 |
| 323 |
RECURRENT CANCER |
21 |
0.0051 |
| 324 |
DISCOURAGEMENT |
12 |
0.0051 |
| 325 |
EPSTEIN-BARR VIRUS INFECTION |
32 |
0.0051 |
| 326 |
CELLULITIS |
258 |
0.0051 |
| 327 |
HAEMORRHAGE URINARY TRACT |
13 |
0.0051 |
| 328 |
IMMUNOSUPPRESSION |
45 |
0.0051 |
| 329 |
SKIN INFECTION |
57 |
0.0051 |
| 330 |
PETECHIAE |
53 |
0.0051 |
| 331 |
PERIODONTITIS |
11 |
0.0051 |
| 332 |
PLEURAL EFFUSION |
308 |
0.0051 |
| 333 |
BK VIRUS INFECTION |
17 |
0.0050 |
| 334 |
BLOOD URIC ACID INCREASED |
29 |
0.0050 |
| 335 |
GASTROINTESTINAL INFECTION |
45 |
0.0050 |
| 336 |
GUILLAIN-BARRE SYNDROME |
24 |
0.0050 |
| 337 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
14 |
0.0049 |
| 338 |
ESCHERICHIA URINARY TRACT INFECTION |
21 |
0.0049 |
| 339 |
PYREXIA |
1700 |
0.0049 |
| 340 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
25 |
0.0049 |
| 341 |
VENOUS THROMBOSIS |
19 |
0.0048 |
| 342 |
PROCTALGIA |
31 |
0.0048 |
| 343 |
SKIN NECROSIS |
25 |
0.0048 |
| 344 |
C-REACTIVE PROTEIN INCREASED |
175 |
0.0048 |
| 345 |
HAEMOLYSIS |
37 |
0.0048 |
| 346 |
GINGIVAL BLEEDING |
65 |
0.0048 |
| 347 |
CHEMOTHERAPY |
18 |
0.0048 |
| 348 |
SUBDURAL HAEMORRHAGE |
13 |
0.0047 |
| 349 |
COLITIS ISCHAEMIC |
32 |
0.0047 |
| 350 |
RESPIRATORY TRACT INFECTION VIRAL |
11 |
0.0047 |
| 351 |
HYPOXIA |
166 |
0.0047 |
| 352 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
41 |
0.0047 |
| 353 |
THERAPY NON-RESPONDER |
211 |
0.0047 |
| 354 |
PULMONARY TOXICITY |
33 |
0.0047 |
| 355 |
PHYSICAL DECONDITIONING |
12 |
0.0047 |
| 356 |
MUCOSAL INFLAMMATION |
122 |
0.0047 |
| 357 |
HYPOKALAEMIA |
215 |
0.0047 |
| 358 |
INFLAMMATORY MARKER INCREASED |
23 |
0.0046 |
| 359 |
MOUTH HAEMORRHAGE |
34 |
0.0046 |
| 360 |
HEPATIC CYTOLYSIS |
59 |
0.0046 |
| 361 |
BLOOD CREATININE ABNORMAL |
16 |
0.0046 |
| 362 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
34 |
0.0046 |
| 363 |
SUPRAVENTRICULAR TACHYCARDIA |
44 |
0.0046 |
| 364 |
THROMBOPHLEBITIS |
16 |
0.0046 |
| 365 |
PARONYCHIA |
20 |
0.0045 |
| 366 |
ACUTE RESPIRATORY FAILURE |
87 |
0.0045 |
| 367 |
CYTOMEGALOVIRUS VIRAEMIA |
20 |
0.0045 |
| 368 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
37 |
0.0045 |
| 369 |
DEVICE RELATED INFECTION |
69 |
0.0045 |
| 370 |
RHINOVIRUS INFECTION |
17 |
0.0044 |
| 371 |
BLOOD UREA INCREASED |
73 |
0.0044 |
| 372 |
LEFT VENTRICULAR FAILURE |
15 |
0.0044 |
| 373 |
LEFT VENTRICULAR DYSFUNCTION |
29 |
0.0043 |
| 374 |
LUNG ADENOCARCINOMA |
13 |
0.0043 |
| 375 |
ANAL FISTULA |
23 |
0.0043 |
| 376 |
WHITE BLOOD CELL COUNT INCREASED |
165 |
0.0043 |
| 377 |
PLATELET COUNT INCREASED |
56 |
0.0043 |
| 378 |
PERFORMANCE STATUS DECREASED |
20 |
0.0043 |
| 379 |
FUNGAL INFECTION |
142 |
0.0043 |
| 380 |
ABSCESS LIMB |
18 |
0.0042 |
| 381 |
CARDIAC FAILURE |
338 |
0.0042 |
| 382 |
HEPATIC ENZYME ABNORMAL |
21 |
0.0042 |
| 383 |
LARGE INTESTINE PERFORATION |
29 |
0.0042 |
| 384 |
SUBCUTANEOUS ABSCESS |
20 |
0.0042 |
| 385 |
SUDDEN DEATH |
44 |
0.0042 |
| 386 |
BLOOD BILIRUBIN INCREASED |
112 |
0.0041 |
| 387 |
MONOCYTE COUNT INCREASED |
15 |
0.0041 |
| 388 |
MULTI-ORGAN FAILURE |
71 |
0.0041 |
| 389 |
ORAL INFECTION |
16 |
0.0041 |
| 390 |
FAILURE TO THRIVE |
21 |
0.0040 |
| 391 |
HERPES SIMPLEX |
26 |
0.0040 |
| 392 |
COLITIS |
151 |
0.0040 |
| 393 |
EMBOLISM |
33 |
0.0040 |
| 394 |
DEATH |
3414 |
0.0040 |
| 395 |
RESPIRATORY TRACT INFECTION |
103 |
0.0040 |
| 396 |
PATHOGEN RESISTANCE |
36 |
0.0039 |
| 397 |
ANAL HAEMORRHAGE |
11 |
0.0039 |
| 398 |
DRUG TOLERANCE DECREASED |
11 |
0.0039 |
| 399 |
CANDIDA INFECTION |
66 |
0.0039 |
| 400 |
CLOSTRIDIUM DIFFICILE INFECTION |
85 |
0.0039 |
| 401 |
INTERSTITIAL LUNG DISEASE |
187 |
0.0039 |
| 402 |
CONGESTIVE CARDIOMYOPATHY |
16 |
0.0038 |
| 403 |
RETINAL VEIN OCCLUSION |
11 |
0.0038 |
| 404 |
BRONCHOPNEUMONIA |
13 |
0.0038 |
| 405 |
ACIDOSIS |
29 |
0.0038 |
| 406 |
UROSEPSIS |
35 |
0.0038 |
| 407 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
266 |
0.0037 |
| 408 |
CHOLANGITIS |
23 |
0.0037 |
| 409 |
ILEUS |
46 |
0.0037 |
| 410 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
65 |
0.0037 |
| 411 |
CONJUNCTIVAL HAEMORRHAGE |
14 |
0.0037 |
| 412 |
NEPHROPATHY TOXIC |
41 |
0.0036 |
| 413 |
TONSILLITIS |
19 |
0.0036 |
| 414 |
CHOLECYSTITIS |
43 |
0.0036 |
| 415 |
ILEUS PARALYTIC |
16 |
0.0036 |
| 416 |
DIVERTICULITIS |
98 |
0.0035 |
| 417 |
MYOCARDIAL ISCHAEMIA |
40 |
0.0035 |
| 418 |
GENERAL PHYSICAL HEALTH DETERIORATION |
405 |
0.0035 |
| 419 |
AORTIC ARTERIOSCLEROSIS |
9 |
0.0035 |
| 420 |
CARDIOTOXICITY |
31 |
0.0035 |
| 421 |
FUNGAL SKIN INFECTION |
14 |
0.0035 |
| 422 |
HAEMORRHAGIC STROKE |
27 |
0.0035 |
| 423 |
HAEMOTHORAX |
10 |
0.0034 |
| 424 |
HYPERVOLAEMIA |
17 |
0.0034 |
| 425 |
ERYTHEMA MULTIFORME |
32 |
0.0034 |
| 426 |
HYPERNATRAEMIA |
17 |
0.0034 |
| 427 |
BRONCHIOLITIS |
12 |
0.0034 |
| 428 |
NEOPLASM PROGRESSION |
116 |
0.0033 |
| 429 |
THERAPY PARTIAL RESPONDER |
52 |
0.0033 |
| 430 |
CENTRAL VENOUS CATHETERISATION |
10 |
0.0033 |
| 431 |
DRUG RESISTANCE |
85 |
0.0033 |
| 432 |
BLOOD COUNT ABNORMAL |
50 |
0.0033 |
| 433 |
PROSTATITIS |
10 |
0.0033 |
| 434 |
CARDIAC FAILURE CHRONIC |
14 |
0.0033 |
| 435 |
CHEST X-RAY ABNORMAL |
10 |
0.0033 |
| 436 |
HYPOPHOSPHATAEMIA |
24 |
0.0032 |
| 437 |
HYPOMAGNESAEMIA |
45 |
0.0032 |
| 438 |
EPISTAXIS |
237 |
0.0032 |
| 439 |
GINGIVITIS |
17 |
0.0031 |
| 440 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
53 |
0.0031 |
| 441 |
MELAENA |
69 |
0.0031 |
| 442 |
NEOPLASM |
36 |
0.0031 |
| 443 |
STAPHYLOCOCCAL INFECTION |
103 |
0.0031 |
| 444 |
IMMUNE SYSTEM DISORDER |
41 |
0.0031 |
| 445 |
BLOOD CREATININE INCREASED |
203 |
0.0031 |
| 446 |
STRESS CARDIOMYOPATHY |
18 |
0.0031 |
| 447 |
FIBRIN D DIMER INCREASED |
11 |
0.0031 |
| 448 |
IMMUNE THROMBOCYTOPENIA |
14 |
0.0031 |
| 449 |
HEPATIC FUNCTION ABNORMAL |
114 |
0.0031 |
| 450 |
CARDIOMYOPATHY |
45 |
0.0030 |
| 451 |
HAEMODYNAMIC INSTABILITY |
23 |
0.0030 |
| 452 |
APPENDICITIS |
28 |
0.0030 |
| 453 |
HEPATITIS CHOLESTATIC |
18 |
0.0030 |
| 454 |
SQUAMOUS CELL CARCINOMA |
28 |
0.0030 |
| 455 |
MYOCARDITIS |
34 |
0.0030 |
| 456 |
NEOPLASM RECURRENCE |
10 |
0.0029 |
| 457 |
ABDOMINAL ABSCESS |
13 |
0.0029 |
| 458 |
PURPURA |
26 |
0.0029 |
| 459 |
CIRCULATORY COLLAPSE |
50 |
0.0029 |
| 460 |
FAECALOMA |
16 |
0.0029 |
| 461 |
ACUTE MYOCARDIAL INFARCTION |
86 |
0.0029 |
| 462 |
HAEMOLYTIC ANAEMIA |
26 |
0.0029 |
| 463 |
THROMBOTIC MICROANGIOPATHY |
28 |
0.0029 |
| 464 |
SKIN MASS |
19 |
0.0028 |
| 465 |
TRANSAMINASES INCREASED |
63 |
0.0028 |
| 466 |
EJECTION FRACTION DECREASED |
44 |
0.0028 |
| 467 |
PULMONARY TUBERCULOSIS |
12 |
0.0028 |
| 468 |
MALIGNANT NEOPLASM PROGRESSION |
287 |
0.0028 |
| 469 |
HERPES VIRUS INFECTION |
16 |
0.0028 |
| 470 |
BLOOD TEST ABNORMAL |
39 |
0.0028 |
| 471 |
LYMPHOCYTE COUNT DECREASED |
49 |
0.0028 |
| 472 |
HEPATITIS ACUTE |
18 |
0.0028 |
| 473 |
ELECTROLYTE IMBALANCE |
32 |
0.0028 |
| 474 |
HEPATIC FAILURE |
83 |
0.0028 |
| 475 |
ELECTROCARDIOGRAM QT PROLONGED |
99 |
0.0027 |
| 476 |
CREATININE RENAL CLEARANCE DECREASED |
11 |
0.0027 |
| 477 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
13 |
0.0027 |
| 478 |
CUTANEOUS VASCULITIS |
10 |
0.0027 |
| 479 |
HYPONATRAEMIA |
154 |
0.0027 |
| 480 |
HYPERTRANSAMINASAEMIA |
19 |
0.0027 |
| 481 |
DIFFUSE LARGE B-CELL LYMPHOMA |
21 |
0.0027 |
| 482 |
INTESTINAL ISCHAEMIA |
15 |
0.0027 |
| 483 |
AMYLASE INCREASED |
10 |
0.0027 |
| 484 |
ATRIAL FIBRILLATION |
263 |
0.0027 |
| 485 |
HUMERUS FRACTURE |
13 |
0.0027 |
| 486 |
MENINGITIS |
18 |
0.0027 |
| 487 |
HEPATOTOXICITY |
60 |
0.0027 |
| 488 |
LUNG DISORDER |
131 |
0.0027 |
| 489 |
HAEMORRHOIDAL HAEMORRHAGE |
13 |
0.0027 |
| 490 |
CEREBRAL INFARCTION |
65 |
0.0027 |
| 491 |
ACUTE CORONARY SYNDROME |
22 |
0.0027 |
| 492 |
RED CELL DISTRIBUTION WIDTH INCREASED |
11 |
0.0026 |
| 493 |
RESPIRATORY DISORDER |
79 |
0.0026 |
| 494 |
ABSCESS |
42 |
0.0026 |
| 495 |
SKIN REACTION |
37 |
0.0026 |
| 496 |
ASCITES |
77 |
0.0026 |
| 497 |
LUMBAR VERTEBRAL FRACTURE |
12 |
0.0026 |
| 498 |
ISCHAEMIA |
12 |
0.0026 |
| 499 |
GASTROENTERITIS |
38 |
0.0026 |
| 500 |
CONSTIPATION |
566 |
0.0026 |
| 501 |
HAEMATOMA |
67 |
0.0026 |
| 502 |
PERIPHERAL SENSORY NEUROPATHY |
15 |
0.0026 |
| 503 |
DISEASE RECURRENCE |
122 |
0.0026 |
| 504 |
GASTROINTESTINAL HAEMORRHAGE |
212 |
0.0025 |
| 505 |
CEREBRAL ISCHAEMIA |
13 |
0.0025 |
| 506 |
PLEURISY |
15 |
0.0025 |
| 507 |
HAEMORRHOIDS |
49 |
0.0025 |
| 508 |
HAEMOPTYSIS |
70 |
0.0025 |
| 509 |
MALNUTRITION |
28 |
0.0025 |
| 510 |
ENTERITIS |
16 |
0.0025 |
| 511 |
TROPONIN INCREASED |
19 |
0.0025 |
| 512 |
VASCULITIS |
29 |
0.0025 |
| 513 |
HYPERTHERMIA |
19 |
0.0025 |
| 514 |
HYPOCALCAEMIA |
47 |
0.0025 |
| 515 |
OFF LABEL USE |
2132 |
0.0024 |
| 516 |
RESPIRATORY DISTRESS |
67 |
0.0024 |
| 517 |
GENERALISED OEDEMA |
30 |
0.0024 |
| 518 |
HAEMATOCRIT DECREASED |
48 |
0.0024 |
| 519 |
CORONAVIRUS INFECTION |
16 |
0.0024 |
| 520 |
ACUTE KIDNEY INJURY |
366 |
0.0024 |
| 521 |
PULMONARY OEDEMA |
107 |
0.0024 |
| 522 |
LOCALISED OEDEMA |
11 |
0.0024 |
| 523 |
MOUTH ULCERATION |
50 |
0.0024 |
| 524 |
LABORATORY TEST ABNORMAL |
70 |
0.0024 |
| 525 |
TOXIC ENCEPHALOPATHY |
12 |
0.0024 |
| 526 |
DELIRIUM |
82 |
0.0024 |
| 527 |
HYPERPYREXIA |
10 |
0.0024 |
| 528 |
GASTRITIS EROSIVE |
11 |
0.0024 |
| 529 |
BLOOD POTASSIUM INCREASED |
38 |
0.0023 |
| 530 |
HAEMATURIA |
80 |
0.0023 |
| 531 |
SHOCK HAEMORRHAGIC |
19 |
0.0023 |
| 532 |
HEPATITIS B |
14 |
0.0023 |
| 533 |
VENTRICULAR TACHYCARDIA |
38 |
0.0023 |
| 534 |
ISCHAEMIC STROKE |
41 |
0.0023 |
| 535 |
TREATMENT FAILURE |
190 |
0.0023 |
| 536 |
RASH MACULO-PAPULAR |
51 |
0.0023 |
| 537 |
BLOOD LACTIC ACID INCREASED |
12 |
0.0023 |
| 538 |
OLIGURIA |
14 |
0.0023 |
| 539 |
HAEMORRHAGE |
235 |
0.0022 |
| 540 |
CARDIOVASCULAR DISORDER |
57 |
0.0022 |
| 541 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
55 |
0.0022 |
| 542 |
DECUBITUS ULCER |
18 |
0.0022 |
| 543 |
INJECTION SITE INFLAMMATION |
11 |
0.0022 |
| 544 |
ANURIA |
19 |
0.0022 |
| 545 |
ORAL CANDIDIASIS |
29 |
0.0022 |
| 546 |
STOMATITIS |
133 |
0.0022 |
| 547 |
JAUNDICE |
59 |
0.0022 |
| 548 |
HYPOPHAGIA |
56 |
0.0022 |
| 549 |
DISEASE COMPLICATION |
10 |
0.0022 |
| 550 |
RENAL IMPAIRMENT |
183 |
0.0022 |
| 551 |
CYTOMEGALOVIRUS INFECTION |
36 |
0.0022 |
| 552 |
STREPTOCOCCAL INFECTION |
12 |
0.0022 |
| 553 |
SQUAMOUS CELL CARCINOMA OF SKIN |
13 |
0.0022 |
| 554 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
22 |
0.0021 |
| 555 |
ANGIOPATHY |
12 |
0.0021 |
| 556 |
SKIN TOXICITY |
12 |
0.0021 |
| 557 |
COAGULOPATHY |
35 |
0.0021 |
| 558 |
INJECTION SITE REACTION |
144 |
0.0021 |
| 559 |
ASPARTATE AMINOTRANSFERASE INCREASED |
111 |
0.0021 |
| 560 |
URINARY RETENTION |
69 |
0.0021 |
| 561 |
RALES |
12 |
0.0021 |
| 562 |
TOOTH ABSCESS |
21 |
0.0021 |
| 563 |
RENAL FAILURE |
273 |
0.0021 |
| 564 |
LIVER DISORDER |
91 |
0.0020 |
| 565 |
ORAL DISORDER |
15 |
0.0020 |
| 566 |
HYPERKALAEMIA |
71 |
0.0020 |
| 567 |
ENCEPHALITIS |
14 |
0.0020 |
| 568 |
CARDIOGENIC SHOCK |
29 |
0.0020 |
| 569 |
ABDOMINAL TENDERNESS |
10 |
0.0020 |
| 570 |
POLYNEUROPATHY |
24 |
0.0020 |
| 571 |
TACHYPNOEA |
27 |
0.0020 |
| 572 |
TOXIC SKIN ERUPTION |
20 |
0.0020 |
| 573 |
DEEP VEIN THROMBOSIS |
129 |
0.0020 |
| 574 |
INGUINAL HERNIA |
12 |
0.0020 |
| 575 |
OEDEMA PERIPHERAL |
237 |
0.0019 |
| 576 |
ALANINE AMINOTRANSFERASE INCREASED |
119 |
0.0019 |
| 577 |
ANGINA PECTORIS |
55 |
0.0019 |
| 578 |
CARDIAC ARREST |
155 |
0.0019 |
| 579 |
SHOCK |
43 |
0.0019 |
| 580 |
PHARYNGITIS |
23 |
0.0019 |
| 581 |
HEPATOMEGALY |
18 |
0.0018 |
| 582 |
COVID-19 |
321 |
0.0018 |
| 583 |
HYPOGAMMAGLOBULINAEMIA |
12 |
0.0018 |
| 584 |
PANCREATITIS ACUTE |
41 |
0.0018 |
| 585 |
PULMONARY MASS |
27 |
0.0018 |
| 586 |
MENTAL STATUS CHANGES |
50 |
0.0018 |
| 587 |
ATRIOVENTRICULAR BLOCK COMPLETE |
12 |
0.0018 |
| 588 |
ENCEPHALOPATHY |
44 |
0.0018 |
| 589 |
SYNCOPE |
178 |
0.0018 |
| 590 |
BLOOD ALBUMIN DECREASED |
14 |
0.0018 |
| 591 |
ALTERED STATE OF CONSCIOUSNESS |
38 |
0.0018 |
| 592 |
BRONCHOSPASM |
25 |
0.0018 |
| 593 |
LOCALISED INFECTION |
42 |
0.0017 |
| 594 |
RHINITIS |
14 |
0.0017 |
| 595 |
HAEMATEMESIS |
44 |
0.0017 |
| 596 |
RENAL TUBULAR NECROSIS |
17 |
0.0017 |
| 597 |
PYELONEPHRITIS |
15 |
0.0017 |
| 598 |
PULMONARY HYPERTENSION |
36 |
0.0017 |
| 599 |
RENAL DISORDER |
80 |
0.0017 |
| 600 |
HEPATIC CIRRHOSIS |
32 |
0.0017 |
| 601 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
93 |
0.0017 |
| 602 |
ANGINA UNSTABLE |
11 |
0.0017 |
| 603 |
SKIN LESION |
46 |
0.0017 |
| 604 |
APHTHOUS ULCER |
13 |
0.0017 |
| 605 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
37 |
0.0017 |
| 606 |
ASTHENIA |
626 |
0.0017 |
| 607 |
DECREASED APPETITE |
385 |
0.0017 |
| 608 |
PULMONARY ARTERIAL HYPERTENSION |
24 |
0.0017 |
| 609 |
CARDIO-RESPIRATORY ARREST |
69 |
0.0016 |
| 610 |
RENAL FAILURE ACUTE |
70 |
0.0016 |
| 611 |
PNEUMONIA ASPIRATION |
41 |
0.0016 |
| 612 |
LYMPHOPENIA |
23 |
0.0016 |
| 613 |
UPPER RESPIRATORY TRACT INFECTION |
75 |
0.0016 |
| 614 |
GENERAL PHYSICAL CONDITION ABNORMAL |
11 |
0.0016 |
| 615 |
BODY TEMPERATURE INCREASED |
33 |
0.0016 |
| 616 |
CONJUNCTIVITIS |
30 |
0.0016 |
| 617 |
LOWER RESPIRATORY TRACT INFECTION |
73 |
0.0016 |
| 618 |
DIARRHOEA HAEMORRHAGIC |
15 |
0.0016 |
| 619 |
FACE OEDEMA |
27 |
0.0016 |
| 620 |
URINARY TRACT INFECTION |
273 |
0.0016 |
| 621 |
HYPOTENSION |
321 |
0.0016 |
| 622 |
DRUG ERUPTION |
28 |
0.0016 |
| 623 |
SPINAL COMPRESSION FRACTURE |
13 |
0.0016 |
| 624 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
15 |
0.0016 |
| 625 |
VIRAL INFECTION |
52 |
0.0016 |
| 626 |
OESOPHAGITIS |
17 |
0.0016 |
| 627 |
WOUND INFECTION |
17 |
0.0016 |
| 628 |
UNEVALUABLE EVENT |
117 |
0.0015 |
| 629 |
ORAL HERPES |
30 |
0.0015 |
| 630 |
TOOTH INFECTION |
20 |
0.0015 |
| 631 |
SARS-COV-2 TEST POSITIVE |
20 |
0.0015 |
| 632 |
ADRENAL INSUFFICIENCY |
18 |
0.0015 |
| 633 |
METABOLIC ACIDOSIS |
47 |
0.0015 |
| 634 |
DRUG-INDUCED LIVER INJURY |
46 |
0.0015 |
| 635 |
PRODUCT USE ISSUE |
275 |
0.0015 |
| 636 |
SMALL INTESTINAL OBSTRUCTION |
18 |
0.0015 |
| 637 |
INFARCTION |
10 |
0.0015 |
| 638 |
CHOLESTASIS |
28 |
0.0015 |
| 639 |
PNEUMOTHORAX |
23 |
0.0014 |
| 640 |
TOXIC EPIDERMAL NECROLYSIS |
22 |
0.0014 |
| 641 |
INJECTION SITE HAEMATOMA |
21 |
0.0014 |
| 642 |
LYMPHOEDEMA |
10 |
0.0014 |
| 643 |
OEDEMA |
78 |
0.0014 |
| 644 |
HYPERGLYCAEMIA |
52 |
0.0014 |
| 645 |
INTESTINAL PERFORATION |
16 |
0.0014 |
| 646 |
ATRIOVENTRICULAR BLOCK |
11 |
0.0014 |
| 647 |
ARRHYTHMIA |
67 |
0.0014 |
| 648 |
RETINAL HAEMORRHAGE |
10 |
0.0014 |
| 649 |
DIARRHOEA |
894 |
0.0014 |
| 650 |
TRICUSPID VALVE INCOMPETENCE |
11 |
0.0014 |
| 651 |
VOMITING |
650 |
0.0014 |
| 652 |
DERMATITIS BULLOUS |
10 |
0.0014 |
| 653 |
HYPERCALCAEMIA |
17 |
0.0014 |
| 654 |
ASPIRATION |
15 |
0.0014 |
| 655 |
NEUTROPHIL COUNT INCREASED |
14 |
0.0014 |
| 656 |
VENTRICULAR FIBRILLATION |
15 |
0.0013 |
| 657 |
SINUS BRADYCARDIA |
13 |
0.0013 |
| 658 |
INTENTIONAL PRODUCT USE ISSUE |
117 |
0.0013 |
| 659 |
NIGHT SWEATS |
43 |
0.0013 |
| 660 |
OSTEOMYELITIS |
24 |
0.0013 |
| 661 |
PULMONARY EMBOLISM |
125 |
0.0013 |
| 662 |
NAUSEA |
1041 |
0.0013 |
| 663 |
NERVOUS SYSTEM DISORDER |
41 |
0.0013 |
| 664 |
GASTROINTESTINAL DISORDER |
117 |
0.0013 |
| 665 |
RENAL FAILURE CHRONIC |
10 |
0.0013 |
| 666 |
HEMIPARESIS |
22 |
0.0013 |
| 667 |
ORAL PAIN |
29 |
0.0013 |
| 668 |
GASTRITIS |
34 |
0.0013 |
| 669 |
NEPHROPATHY |
12 |
0.0013 |
| 670 |
BASAL CELL CARCINOMA |
20 |
0.0013 |
| 671 |
TASTE DISORDER |
26 |
0.0013 |
| 672 |
DYSPNOEA EXERTIONAL |
48 |
0.0013 |
| 673 |
ADVERSE EVENT |
117 |
0.0013 |
| 674 |
PALLOR |
34 |
0.0012 |
| 675 |
BLOOD CALCIUM DECREASED |
14 |
0.0012 |
| 676 |
RESPIRATORY RATE INCREASED |
11 |
0.0012 |
| 677 |
TOXICITY TO VARIOUS AGENTS |
208 |
0.0012 |
| 678 |
HOSPITALISATION |
189 |
0.0012 |
| 679 |
POLYURIA |
10 |
0.0012 |
| 680 |
CARDIOMEGALY |
15 |
0.0012 |
| 681 |
HICCUPS |
10 |
0.0012 |
| 682 |
CHILLS |
142 |
0.0012 |
| 683 |
ORTHOSTATIC HYPOTENSION |
21 |
0.0012 |
| 684 |
DECREASED ACTIVITY |
13 |
0.0012 |
| 685 |
HEPATOCELLULAR INJURY |
17 |
0.0012 |
| 686 |
PULMONARY FIBROSIS |
23 |
0.0012 |
| 687 |
BLOOD POTASSIUM DECREASED |
36 |
0.0012 |
| 688 |
BRAIN NEOPLASM |
11 |
0.0012 |
| 689 |
CARDIAC DISORDER |
112 |
0.0012 |
| 690 |
INCREASED TENDENCY TO BRUISE |
11 |
0.0012 |
| 691 |
DERMATITIS ALLERGIC |
15 |
0.0012 |
| 692 |
EMPHYSEMA |
12 |
0.0012 |
| 693 |
RECTAL HAEMORRHAGE |
51 |
0.0012 |
| 694 |
AORTIC ANEURYSM |
9 |
0.0012 |
| 695 |
INFLAMMATION |
61 |
0.0012 |
| 696 |
HEPATITIS |
30 |
0.0012 |
| 697 |
GOUT |
21 |
0.0012 |
| 698 |
CONFUSIONAL STATE |
189 |
0.0012 |
| 699 |
LIVER FUNCTION TEST ABNORMAL |
34 |
0.0012 |
| 700 |
FLUID OVERLOAD |
17 |
0.0012 |
| 701 |
OXYGEN SATURATION DECREASED |
65 |
0.0012 |
| 702 |
MITRAL VALVE INCOMPETENCE |
13 |
0.0011 |
| 703 |
FOLLICULITIS |
12 |
0.0011 |
| 704 |
COLON CANCER |
17 |
0.0011 |
| 705 |
LIVER INJURY |
28 |
0.0011 |
| 706 |
DRUG INTOLERANCE |
110 |
0.0011 |
| 707 |
AUTOIMMUNE DISORDER |
11 |
0.0011 |
| 708 |
EPILEPSY |
34 |
0.0011 |
| 709 |
PERITONITIS |
23 |
0.0011 |
| 710 |
THERAPEUTIC RESPONSE DECREASED |
67 |
0.0011 |
| 711 |
ABDOMINAL PAIN |
257 |
0.0011 |
| 712 |
NEUROPATHY PERIPHERAL |
105 |
0.0011 |
| 713 |
DERMATITIS |
23 |
0.0011 |
| 714 |
PRODUCT USE IN UNAPPROVED INDICATION |
267 |
0.0011 |
| 715 |
NODULE |
14 |
0.0011 |
| 716 |
PRESYNCOPE |
26 |
0.0011 |
| 717 |
EYE INFECTION |
12 |
0.0011 |
| 718 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
42 |
0.0011 |
| 719 |
TACHYCARDIA |
94 |
0.0011 |
| 720 |
INTERNAL HAEMORRHAGE |
12 |
0.0010 |
| 721 |
DEHYDRATION |
140 |
0.0010 |
| 722 |
TOOTHACHE |
19 |
0.0010 |
| 723 |
GASTRIC HAEMORRHAGE |
12 |
0.0010 |
| 724 |
POST PROCEDURAL COMPLICATION |
20 |
0.0010 |
| 725 |
BONE PAIN |
61 |
0.0010 |
| 726 |
DRUG INTERACTION |
165 |
0.0010 |
| 727 |
CHOLELITHIASIS |
34 |
0.0010 |
| 728 |
NEUROTOXICITY |
18 |
0.0010 |
| 729 |
SPINAL PAIN |
12 |
0.0010 |
| 730 |
SKIN DISORDER |
34 |
0.0010 |
| 731 |
THROMBOSIS |
82 |
0.0010 |
| 732 |
CONTUSION |
98 |
0.0010 |
| 733 |
FAECES DISCOLOURED |
22 |
0.0010 |
| 734 |
PULMONARY THROMBOSIS |
11 |
0.0010 |
| 735 |
CYSTITIS |
32 |
0.0010 |
| 736 |
HIATUS HERNIA |
13 |
0.0010 |
| 737 |
FATIGUE |
781 |
0.0010 |
| 738 |
BRONCHITIS |
74 |
0.0010 |
| 739 |
ANGIOEDEMA |
44 |
0.0010 |
| 740 |
CARDIAC FAILURE CONGESTIVE |
79 |
0.0010 |
| 741 |
HEPATIC ENZYME INCREASED |
67 |
0.0010 |
| 742 |
DRUG LEVEL DECREASED |
10 |
0.0010 |
| 743 |
DYSURIA |
36 |
0.0010 |
| 744 |
GLOMERULAR FILTRATION RATE DECREASED |
12 |
0.0010 |
| 745 |
HERPES ZOSTER |
56 |
0.0010 |
| 746 |
SKIN ULCER |
25 |
0.0010 |
| 747 |
DEMENTIA |
27 |
0.0010 |
| 748 |
FALL |
320 |
0.0010 |
| 749 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
50 |
0.0010 |
| 750 |
BLOOD SODIUM DECREASED |
18 |
0.0010 |
| 751 |
ACUTE HEPATIC FAILURE |
13 |
0.0010 |
| 752 |
MUSCLE ATROPHY |
12 |
0.0009 |
| 753 |
POST PROCEDURAL HAEMORRHAGE |
11 |
0.0009 |
| 754 |
NEOPLASM MALIGNANT |
63 |
0.0009 |
| 755 |
ULCER |
15 |
0.0009 |
| 756 |
APHASIA |
28 |
0.0009 |
| 757 |
ATAXIA |
11 |
0.0009 |
| 758 |
DRUG INEFFECTIVE |
1218 |
0.0009 |
| 759 |
HEAD INJURY |
29 |
0.0009 |
| 760 |
SINUS TACHYCARDIA |
13 |
0.0009 |
| 761 |
FEMUR FRACTURE |
28 |
0.0009 |
| 762 |
DENTAL CARIES |
10 |
0.0009 |
| 763 |
LYMPHADENOPATHY |
32 |
0.0009 |
| 764 |
CEREBROVASCULAR ACCIDENT |
153 |
0.0009 |
| 765 |
INTESTINAL OBSTRUCTION |
34 |
0.0009 |
| 766 |
STEVENS-JOHNSON SYNDROME |
20 |
0.0009 |
| 767 |
SKIN HAEMORRHAGE |
13 |
0.0009 |
| 768 |
POISONING |
11 |
0.0009 |
| 769 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
15 |
0.0009 |
| 770 |
RASH |
378 |
0.0009 |
| 771 |
INFLUENZA |
96 |
0.0009 |
| 772 |
MASS |
12 |
0.0009 |
| 773 |
DYSPNOEA |
486 |
0.0009 |
| 774 |
HAEMATOCHEZIA |
47 |
0.0009 |
| 775 |
SPINAL FRACTURE |
17 |
0.0008 |
| 776 |
LYMPHOMA |
13 |
0.0008 |
| 777 |
MUSCULOSKELETAL DISORDER |
16 |
0.0008 |
| 778 |
PRODUCT PRESCRIBING ISSUE |
18 |
0.0008 |
| 779 |
INTERNATIONAL NORMALISED RATIO INCREASED |
23 |
0.0008 |
| 780 |
ADVERSE DRUG REACTION |
72 |
0.0008 |
| 781 |
PANCREATITIS |
42 |
0.0008 |
| 782 |
BRADYCARDIA |
42 |
0.0008 |
| 783 |
LIVER FUNCTION TEST INCREASED |
17 |
0.0008 |
| 784 |
WEIGHT DECREASED |
221 |
0.0008 |
| 785 |
CONDITION AGGRAVATED |
240 |
0.0008 |
| 786 |
INJECTION SITE IRRITATION |
10 |
0.0008 |
| 787 |
COMA |
37 |
0.0008 |
| 788 |
COUGH |
217 |
0.0008 |
| 789 |
INJECTION SITE INDURATION |
10 |
0.0008 |
| 790 |
TRANSIENT ISCHAEMIC ATTACK |
26 |
0.0008 |
| 791 |
BLOOD PRESSURE DECREASED |
51 |
0.0008 |
| 792 |
RHABDOMYOLYSIS |
32 |
0.0008 |
| 793 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
22 |
0.0008 |
| 794 |
GASTRIC CANCER |
19 |
0.0007 |
| 795 |
DYSPHAGIA |
71 |
0.0007 |
| 796 |
MALIGNANT MELANOMA |
10 |
0.0007 |
| 797 |
HIP FRACTURE |
24 |
0.0007 |
| 798 |
CHEST PAIN |
137 |
0.0007 |
| 799 |
MYOCARDIAL INFARCTION |
129 |
0.0007 |
| 800 |
PRODUCTIVE COUGH |
35 |
0.0007 |
| 801 |
OSTEOPENIA |
11 |
0.0007 |
| 802 |
PLASMA CELL MYELOMA |
28 |
0.0007 |
| 803 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
32 |
0.0007 |
| 804 |
INJECTION SITE ERYTHEMA |
88 |
0.0007 |
| 805 |
RASH PRURITIC |
38 |
0.0007 |
| 806 |
PARALYSIS |
10 |
0.0007 |
| 807 |
HEPATIC STEATOSIS |
13 |
0.0007 |
| 808 |
BACK PAIN |
162 |
0.0007 |
| 809 |
SINUSITIS |
71 |
0.0007 |
| 810 |
RASH ERYTHEMATOUS |
33 |
0.0007 |
| 811 |
DEAFNESS |
18 |
0.0007 |
| 812 |
FLUID RETENTION |
35 |
0.0007 |
| 813 |
OSTEONECROSIS OF JAW |
17 |
0.0007 |
| 814 |
PROTEINURIA |
13 |
0.0007 |
| 815 |
DISORIENTATION |
27 |
0.0007 |
| 816 |
URINARY INCONTINENCE |
20 |
0.0007 |
| 817 |
UPPER LIMB FRACTURE |
13 |
0.0007 |
| 818 |
PRESCRIBED UNDERDOSE |
13 |
0.0007 |
| 819 |
ARTHRITIS |
51 |
0.0006 |
| 820 |
DELUSION |
10 |
0.0006 |
| 821 |
FEEDING DISORDER |
13 |
0.0006 |
| 822 |
APPLICATION SITE PAIN |
14 |
0.0006 |
| 823 |
PRODUCT USE COMPLAINT |
10 |
0.0006 |
| 824 |
ABDOMINAL PAIN LOWER |
16 |
0.0006 |
| 825 |
ERYTHEMA |
130 |
0.0006 |
| 826 |
SLEEP APNOEA SYNDROME |
12 |
0.0006 |
| 827 |
CORONARY ARTERY DISEASE |
19 |
0.0006 |
| 828 |
EAR PAIN |
12 |
0.0006 |
| 829 |
DIABETES MELLITUS |
47 |
0.0006 |
| 830 |
OROPHARYNGEAL PAIN |
57 |
0.0006 |
| 831 |
BLOOD PRESSURE ABNORMAL |
12 |
0.0006 |
| 832 |
PRODUCT ADMINISTRATION ERROR |
12 |
0.0006 |
| 833 |
LUNG NEOPLASM MALIGNANT |
24 |
0.0006 |
| 834 |
DYSPEPSIA |
57 |
0.0006 |
| 835 |
ABDOMINAL DISTENSION |
60 |
0.0006 |
| 836 |
SEIZURE |
66 |
0.0006 |
| 837 |
HALLUCINATION, VISUAL |
12 |
0.0006 |
| 838 |
OSTEOARTHRITIS |
24 |
0.0006 |
| 839 |
HYPERTENSION |
118 |
0.0006 |
| 840 |
CYTOKINE RELEASE SYNDROME |
11 |
0.0005 |
| 841 |
MALAISE |
240 |
0.0005 |
| 842 |
SKIN EXFOLIATION |
46 |
0.0005 |
| 843 |
RESPIRATORY ARREST |
15 |
0.0005 |
| 844 |
PRODUCT PREPARATION ERROR |
11 |
0.0005 |
| 845 |
MUSCULOSKELETAL PAIN |
28 |
0.0005 |
| 846 |
TUBULOINTERSTITIAL NEPHRITIS |
10 |
0.0005 |
| 847 |
HYPOTHYROIDISM |
17 |
0.0005 |
| 848 |
DIZZINESS |
265 |
0.0005 |
| 849 |
LOSS OF CONSCIOUSNESS |
68 |
0.0005 |
| 850 |
FRACTURE |
10 |
0.0005 |
| 851 |
GASTRIC ULCER |
10 |
0.0005 |
| 852 |
ANAPHYLACTIC REACTION |
29 |
0.0005 |
| 853 |
RASH MACULAR |
18 |
0.0005 |
| 854 |
MUSCULAR WEAKNESS |
58 |
0.0005 |
| 855 |
VERTIGO |
31 |
0.0005 |
| 856 |
ILLNESS |
52 |
0.0005 |
| 857 |
DYSARTHRIA |
19 |
0.0005 |
| 858 |
UNRESPONSIVE TO STIMULI |
13 |
0.0005 |
| 859 |
NECK PAIN |
28 |
0.0005 |
| 860 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
24 |
0.0005 |
| 861 |
RHINORRHOEA |
32 |
0.0005 |
| 862 |
PAIN IN JAW |
14 |
0.0005 |
| 863 |
CHROMATURIA |
11 |
0.0005 |
| 864 |
LETHARGY |
28 |
0.0005 |
| 865 |
DYSGEUSIA |
36 |
0.0005 |
| 866 |
FREQUENT BOWEL MOVEMENTS |
13 |
0.0005 |
| 867 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
14 |
0.0005 |
| 868 |
ECZEMA |
25 |
0.0005 |
| 869 |
HALLUCINATION |
36 |
0.0005 |
| 870 |
DRUG EFFECT INCOMPLETE |
17 |
0.0005 |
| 871 |
URTICARIA |
78 |
0.0005 |
| 872 |
POOR QUALITY SLEEP |
10 |
0.0005 |
| 873 |
RASH GENERALISED |
12 |
0.0005 |
| 874 |
ABDOMINAL PAIN UPPER |
95 |
0.0005 |
| 875 |
APPLICATION SITE ERYTHEMA |
12 |
0.0005 |
| 876 |
PRURITUS |
175 |
0.0005 |
| 877 |
HYPOGLYCAEMIA |
22 |
0.0005 |
| 878 |
ABDOMINAL DISCOMFORT |
76 |
0.0005 |
| 879 |
DEPRESSED MOOD |
23 |
0.0004 |
| 880 |
GASTROOESOPHAGEAL REFLUX DISEASE |
35 |
0.0004 |
| 881 |
HEART RATE INCREASED |
43 |
0.0004 |
| 882 |
CHEST DISCOMFORT |
44 |
0.0004 |
| 883 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
10 |
0.0004 |
| 884 |
HEART RATE DECREASED |
15 |
0.0004 |
| 885 |
PERIPHERAL SWELLING |
65 |
0.0004 |
| 886 |
MENTAL IMPAIRMENT |
10 |
0.0004 |
| 887 |
INFUSION RELATED REACTION |
27 |
0.0004 |
| 888 |
LIMB INJURY |
11 |
0.0004 |
| 889 |
MOBILITY DECREASED |
29 |
0.0004 |
| 890 |
PREMATURE BABY |
12 |
0.0004 |
| 891 |
IMPAIRED HEALING |
13 |
0.0004 |
| 892 |
OSTEONECROSIS |
13 |
0.0004 |
| 893 |
WOUND |
11 |
0.0004 |
| 894 |
GAIT INABILITY |
13 |
0.0004 |
| 895 |
DEPRESSION |
88 |
0.0004 |
| 896 |
COGNITIVE DISORDER |
18 |
0.0004 |
| 897 |
SWELLING |
36 |
0.0004 |
| 898 |
POLLAKIURIA |
16 |
0.0004 |
| 899 |
CHRONIC KIDNEY DISEASE |
29 |
0.0004 |
| 900 |
PAIN IN EXTREMITY |
112 |
0.0004 |
| 901 |
GASTRIC DISORDER |
13 |
0.0004 |
| 902 |
DISCOMFORT |
23 |
0.0004 |
| 903 |
HYPOACUSIS |
16 |
0.0004 |
| 904 |
LACTIC ACIDOSIS |
12 |
0.0004 |
| 905 |
PAIN |
226 |
0.0004 |
| 906 |
MENTAL DISORDER |
16 |
0.0004 |
| 907 |
HYPERHIDROSIS |
47 |
0.0004 |
| 908 |
GAIT DISTURBANCE |
69 |
0.0004 |
| 909 |
SOMNOLENCE |
72 |
0.0004 |
| 910 |
MYALGIA |
60 |
0.0004 |
| 911 |
NEPHROLITHIASIS |
16 |
0.0003 |
| 912 |
ARTHRALGIA |
143 |
0.0003 |
| 913 |
SPEECH DISORDER |
18 |
0.0003 |
| 914 |
DYSSTASIA |
10 |
0.0003 |
| 915 |
DYSPHONIA |
20 |
0.0003 |
| 916 |
ALOPECIA |
67 |
0.0003 |
| 917 |
BLISTER |
19 |
0.0003 |
| 918 |
BALANCE DISORDER |
29 |
0.0003 |
| 919 |
NO ADVERSE EVENT |
60 |
0.0003 |
| 920 |
UNDERDOSE |
24 |
0.0003 |
| 921 |
INSOMNIA |
87 |
0.0003 |
| 922 |
SKIN DISCOLOURATION |
15 |
0.0003 |
| 923 |
INJECTION SITE RASH |
10 |
0.0003 |
| 924 |
HYPOAESTHESIA |
47 |
0.0003 |
| 925 |
MOVEMENT DISORDER |
10 |
0.0003 |
| 926 |
TREATMENT NONCOMPLIANCE |
17 |
0.0003 |
| 927 |
PRODUCT STORAGE ERROR |
27 |
0.0003 |
| 928 |
WEIGHT INCREASED |
69 |
0.0003 |
| 929 |
PROSTATE CANCER |
24 |
0.0003 |
| 930 |
TYPE 2 DIABETES MELLITUS |
10 |
0.0003 |
| 931 |
HEADACHE |
185 |
0.0003 |
| 932 |
OSTEOPOROSIS |
12 |
0.0003 |
| 933 |
HYPERSENSITIVITY |
54 |
0.0003 |
| 934 |
INJECTION SITE PAIN |
89 |
0.0003 |
| 935 |
FEELING ABNORMAL |
69 |
0.0003 |
| 936 |
SKIN IRRITATION |
13 |
0.0003 |
| 937 |
VISUAL IMPAIRMENT |
35 |
0.0003 |
| 938 |
PALPITATIONS |
33 |
0.0003 |
| 939 |
DRY EYE |
14 |
0.0003 |
| 940 |
INJECTION SITE MASS |
10 |
0.0003 |
| 941 |
CATARACT |
16 |
0.0003 |
| 942 |
JOINT SWELLING |
32 |
0.0003 |
| 943 |
SWELLING FACE |
17 |
0.0003 |
| 944 |
NASOPHARYNGITIS |
48 |
0.0003 |
| 945 |
BLADDER CANCER |
15 |
0.0003 |
| 946 |
TREMOR |
42 |
0.0003 |
| 947 |
WHEEZING |
15 |
0.0003 |
| 948 |
MUSCLE SPASMS |
46 |
0.0003 |
| 949 |
DYSKINESIA |
10 |
0.0002 |
| 950 |
THERAPEUTIC RESPONSE UNEXPECTED |
11 |
0.0002 |
| 951 |
INFLUENZA LIKE ILLNESS |
20 |
0.0002 |
| 952 |
BLOOD GLUCOSE INCREASED |
45 |
0.0002 |
| 953 |
AMNESIA |
15 |
0.0002 |
| 954 |
VAGINAL HAEMORRHAGE |
10 |
0.0002 |
| 955 |
CONVULSION |
13 |
0.0002 |
| 956 |
COLITIS ULCERATIVE |
10 |
0.0002 |
| 957 |
DISTURBANCE IN ATTENTION |
12 |
0.0002 |
| 958 |
BLOOD PRESSURE INCREASED |
34 |
0.0002 |
| 959 |
DRY MOUTH |
18 |
0.0002 |
| 960 |
INJURY |
15 |
0.0002 |
| 961 |
EYE PAIN |
12 |
0.0002 |
| 962 |
FLATULENCE |
12 |
0.0002 |
| 963 |
AGITATION |
15 |
0.0002 |
| 964 |
PARAESTHESIA |
32 |
0.0002 |
| 965 |
IRRITABILITY |
12 |
0.0002 |
| 966 |
ARTHROPATHY |
11 |
0.0002 |
| 967 |
MEMORY IMPAIRMENT |
25 |
0.0002 |
| 968 |
ILL-DEFINED DISORDER |
11 |
0.0002 |
| 969 |
MEDICATION ERROR |
10 |
0.0002 |
| 970 |
DRY SKIN |
24 |
0.0002 |
| 971 |
INJECTION SITE PRURITUS |
12 |
0.0002 |
| 972 |
MUSCULOSKELETAL STIFFNESS |
15 |
0.0002 |
| 973 |
NASAL CONGESTION |
10 |
0.0002 |
| 974 |
SLEEP DISORDER |
12 |
0.0002 |
| 975 |
INJECTION SITE SWELLING |
13 |
0.0002 |
| 976 |
ANXIETY |
47 |
0.0002 |
| 977 |
FEELING HOT |
10 |
0.0002 |
| 978 |
INCORRECT DOSE ADMINISTERED |
37 |
0.0002 |
| 979 |
FLUSHING |
16 |
0.0002 |
| 980 |
MATERNAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 981 |
ASTHMA |
17 |
0.0002 |
| 982 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 983 |
VISION BLURRED |
19 |
0.0001 |
| 984 |
INTENTIONAL PRODUCT MISUSE |
12 |
0.0001 |
| 985 |
FOETAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 986 |
HOT FLUSH |
10 |
0.0001 |
| 987 |
PRODUCT DOSE OMISSION ISSUE |
38 |
0.0001 |
| 988 |
INJECTION SITE HAEMORRHAGE |
10 |
0.0001 |
| 989 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
22 |
0.0001 |
| 990 |
MIGRAINE |
10 |
0.0001 |
| 991 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
19 |
0.0001 |
| 992 |
OVERDOSE |
18 |
0.0001 |
| 993 |
PRODUCT QUALITY ISSUE |
11 |
0.0001 |
| 994 |
DRUG DOSE OMISSION |
11 |
0.0001 |